111 Inc (YI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, 111 Inc (YI) has a cash flow conversion efficiency ratio of -3.363x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-91.72 Million) by net assets ($27.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of 111 Inc for the company's overall valuation and market capitalisation.
111 Inc - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how 111 Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
111 Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of 111 Inc ranked by their cash flow conversion efficiency. See 111 Inc cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
POZZI MILANO S.P.A.
F:7TL
|
N/A |
|
Sama Resources Inc.
V:SME
|
-0.002x |
|
Scibase AB
ST:SCIB
|
-0.457x |
|
Swoop Holdings Ltd
AU:SWP
|
-0.066x |
|
Genolution Inc.
KQ:225220
|
-0.013x |
|
Carawine Resources Ltd
AU:CWX
|
-0.016x |
|
SemiLEDS Corporation
NASDAQ:LEDS
|
0.714x |
|
FGI Industries Ltd
NASDAQ:FGI
|
0.142x |
Annual Cash Flow Conversion Efficiency for 111 Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of 111 Inc from 2016 to 2025. View 111 Inc (YI) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $214.56 Million | $119.14 Million | 0.555x | -19.61% |
| 2024-12-31 | $380.76 Million | $263.02 Million | 0.691x | +142.64% |
| 2023-12-31 | $276.10 Million | $-447.24 Million | -1.620x | -4435.40% |
| 2022-12-31 | $648.24 Million | $-23.15 Million | -0.036x | +95.28% |
| 2021-12-31 | $848.71 Million | $-641.94 Million | -0.756x | -761.87% |
| 2020-12-31 | $1.33 Billion | $-116.78 Million | -0.088x | +86.69% |
| 2019-12-31 | $773.92 Million | $-510.19 Million | -0.659x | -135.19% |
| 2018-12-31 | $1.22 Billion | $-343.02 Million | -0.280x | +56.27% |
| 2017-12-31 | $318.82 Million | $-204.37 Million | -0.641x | +5.07% |
| 2016-12-31 | $575.52 Million | $-388.65 Million | -0.675x | -- |
About 111 Inc
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education,… Read more